Smart Biotech Hedge Fund Worth Watching Had Therapeutics MD Before Pop |
| July 10, 2014 | July 2014 Bond Updates |
|
Biotech stock Therapeutics MD (TXMD) was up 32.5% on Tuesday, lifted by brokerage house FBR Capital initiating coverage with an incredible $34 price target. Based on TXMD's Tuesday closing price of $5.47, the FBR price target would mean a 600% return. |
| View more at: http://www.forbes.com/sites/greatspeculations/2014/07/09/smart-biotech-hedge-fund-worth-watching-had-therapeutics-md-before-pop/ |